Overview

Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo

Status:
Recruiting
Trial end date:
2021-08-30
Target enrollment:
Participant gender:
Summary
The aim of the present work is to evaluate the efficacy and safety of diphenylcyclopropenone (DPCP) as a depigmenting therapy in extensive Vitiligo.
Phase:
Phase 4
Details
Lead Sponsor:
Ain Shams University